Corbus Pharmaceuticals Holdings (CRBP) Return on Assets (2014 - 2025)

Corbus Pharmaceuticals Holdings' Return on Assets history runs 12 years deep, the most recent figure standing at 0.0% for Q4 2025.

• On a quarterly basis, Return on Assets changed 0.0% year-over-year to 0.0% in Q4 2025; TTM through Dec 2025 was 0.0%, a 0.0% change from a year earlier, with the FY2024 full-year figure at 0.0%, up 3.0% from the prior year.
• Return on Assets advanced to 0.0% in Q4 2025 per CRBP's latest filing, from 0.0% in the prior quarter.
• Across five years, Return on Assets topped out at 0.0% in Q2 2025 and bottomed at 0.03% in Q4 2023.
• The 5-year median for Return on Assets is 0.01% (2024), against an average of 0.01%.
• Across the five-year window, Return on Assets decreased 2 bps in 2023 and climbed 2 bps in 2024, its largest moves.
• Year by year, Return on Assets stood at 0.01% in 2021, then jumped by 40 bps to 0.01% in 2022, then plunged by 208 bps to 0.03% in 2023, then surged by 91 bps to 0.0% in 2024, then increased by 28 bps to 0.0% in 2025.
• Per Business Quant, the three latest CRBP Return on Assets figures stand at 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025).